Bristol Myers Squibb reported Q1 2026 revenue of $11.49 billion, net income of $2.68 billion and cash of $9.57 billion. The thesis depends on new product growth, loss-of-exclusivity management, pipeline execution and debt/cash discipline.
Bristol Myers: the patent cliff has to meet a real pipeline bridge
NYSEBMYCoverage BootstrapBristol Myers Squibb Company
Thesis summary
Bristol Myers Squibb reported Q1 2026 revenue of $11.49 billion, net income of $2.68 billion and cash of $9.57 billion. The thesis depends on new product growth, loss-of-exclusivity management, pipeline execution and debt/cash discipline.
View article
Discuss the thesis
0 commentsCommenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.
No comments yet. Start the discussion with evidence, a question, or a bear case.